A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety, and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026)

AIDS Research and Human Retroviruses, Ahead of Print.

Source: AIDS Research and Human Retroviruses - December 6, 2021 Category: Infectious Diseases Authors: Ross D. Cranston Elizabeth Brown Jos é Bauermeister Eileen F. Dunne Craig Hoesley Ken Ho Sherri Johnson Jonathan Lucas Clara Dominguez-Islas Holly Gundacker Melissa Peda Cindy E. Jacobson Lindsay Kramzer Devika Singh Charlene S. Dezzutti Ratiya Pamela Ku Source Type: research